Overall response rates according to chemotherapy regimen (all stages)
| Treatment regimen . | CR (%) . | PR (%) . | ORR (%) . |
|---|---|---|---|
| R-CHOP | 17/20 (85) | 3/20 (15) | 20/20 (100) |
| R-CHOP + RT | 7/7 (100) | 0 (0) | 7/7 (100) |
| R-CHOP all RT | 24/27 (89) | 3/27 (11) | 27/27 (100) |
| R-ABVD | 2/3 (67) | 1/3 (33) | 3 (100) |
| R-ABVD + RT | 0 | 0 | 0 |
| R-ABVD all RT | 2 (67) | 1/3 (33) | 3 (100) |
| ABVD | 2/2 (100) | 0 (0) | 2/2 (100) |
| ABVD + RT | 1/1 (100) | 0 (0) | 1/1 (100) |
| ABVD all RT | 3/3 (100) | 0 (0) | 3/3 (100) |
| R | 0 (0) | 1/1 (100) | 1/1 (100) |
| R + RT | 2/3 (67) | 1/3 (33) | 3/3 (100) |
| R all RT | 2/4 (50) | 2/4 (50) | 4/4 (100) |
| Other regimens | 2 (100) | 0 (0) | 2 (100) |
| All systemic therapy ± RT | 33/39 (85%) | 6/39 (15%) | 39/39 (100) |
| Treatment regimen . | CR (%) . | PR (%) . | ORR (%) . |
|---|---|---|---|
| R-CHOP | 17/20 (85) | 3/20 (15) | 20/20 (100) |
| R-CHOP + RT | 7/7 (100) | 0 (0) | 7/7 (100) |
| R-CHOP all RT | 24/27 (89) | 3/27 (11) | 27/27 (100) |
| R-ABVD | 2/3 (67) | 1/3 (33) | 3 (100) |
| R-ABVD + RT | 0 | 0 | 0 |
| R-ABVD all RT | 2 (67) | 1/3 (33) | 3 (100) |
| ABVD | 2/2 (100) | 0 (0) | 2/2 (100) |
| ABVD + RT | 1/1 (100) | 0 (0) | 1/1 (100) |
| ABVD all RT | 3/3 (100) | 0 (0) | 3/3 (100) |
| R | 0 (0) | 1/1 (100) | 1/1 (100) |
| R + RT | 2/3 (67) | 1/3 (33) | 3/3 (100) |
| R all RT | 2/4 (50) | 2/4 (50) | 4/4 (100) |
| Other regimens | 2 (100) | 0 (0) | 2 (100) |
| All systemic therapy ± RT | 33/39 (85%) | 6/39 (15%) | 39/39 (100) |
Boldface type indicates subtotal.